165 related articles for article (PubMed ID: 17332654)
1. Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions.
Kalantri Y; Naik G; Joshi SP; Jain A; Phatak S; Chavan R; Hemvani N; Chitnis DS
Indian J Med Res; 2007 Jan; 125(1):25-30. PubMed ID: 17332654
[TBL] [Abstract][Full Text] [Related]
2. Pleural cancer antigen-125 levels in benign and malignant pleural effusions.
Choi WI; Qama D; Lee MY; Kwon KY
Int J Tuberc Lung Dis; 2013 May; 17(5):693-7. PubMed ID: 23575338
[TBL] [Abstract][Full Text] [Related]
3. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
[TBL] [Abstract][Full Text] [Related]
4. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids.
Sevinc A; Buyukberber S; Sari R; Kiroglu Y; Turk HM; Ates M
Gynecol Oncol; 2000 May; 77(2):254-7. PubMed ID: 10785474
[TBL] [Abstract][Full Text] [Related]
6. Role of pleural fluid cholesterol in differentiating transudative from exudative pleural effusion.
Guleria R; Agarwal SR; Sinha S; Pande JN; Misra A
Natl Med J India; 2003; 16(2):64-9. PubMed ID: 12816183
[TBL] [Abstract][Full Text] [Related]
7. [CA 125 in the department of internal medicine--a marker of ovarian tumor, thoracic fluid or ascites?].
Kasalický P; Kocián J
Vnitr Lek; 1998 Aug; 44(8):478-80. PubMed ID: 10358454
[TBL] [Abstract][Full Text] [Related]
8. Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results.
Jenkinson F; Murphy MJ
Ann Clin Biochem; 2007 Sep; 44(Pt 5):471-3. PubMed ID: 17761034
[TBL] [Abstract][Full Text] [Related]
9. Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis.
Bandyopadhyay R; Bandyopadhyay SK; Ghosal J; Kumar U; Dutta A
J Indian Med Assoc; 2006 Apr; 104(4):174, 176-7, 185. PubMed ID: 16910322
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor levels in pleural and peritoneal fluid in Meigs' syndrome.
Ishiko O; Yoshida H; Sumi T; Hirai K; Ogita S
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):129-30. PubMed ID: 11516814
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
12. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
Zhang JR; Zhang XY; Chen XT
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
[TBL] [Abstract][Full Text] [Related]
13. [High Ca 125 serum level in benign ascites or pleural effusion].
Mezger J; Häussinger KE; Wilmanns W; Lamerz R
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
[TBL] [Abstract][Full Text] [Related]
14. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic characteristics and their significance in malignant, tuberculous and cirrhotic pleural and ascitic fluids.
Lu XG; Mao JS; Tong JF; Zhu L; Liu J; Gong XB; Huang J
Int J Lab Hematol; 2007 Apr; 29(2):132-8. PubMed ID: 17474886
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of tumor-associated antigens and total sialic acid levels in effusions of malignant and benign origin.
Yenisey C; Yenice S; Güner G; Güner S
Biochem Soc Trans; 1996 May; 24(2):301S. PubMed ID: 8736959
[No Abstract] [Full Text] [Related]
17. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
18. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the diagnostic yield and safety of closed pleural biopsy in the diagnosis of pleural effusion.
James P; Gupta R; Christopher DJ; Balamugesh T
Indian J Tuberc; 2010 Jan; 57(1):19-24. PubMed ID: 20420040
[TBL] [Abstract][Full Text] [Related]
20. The lactate dehydrogenases in malignant and non-malignant diseases.
Oladipo OO; Ajala MO; Afonja OA
Niger Postgrad Med J; 2002 Mar; 9(1):1-6. PubMed ID: 11932752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
